CTEV logo

CLARITEV CORP

CTEVNYSE
πŸ† #3051 by market capEarnings Nov 9US Equity
β€”β€”
Quote unavailable
πŸ””
Track CTEV
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$384M
Small Cap
πŸ“ˆRevenue Growth (YoY)
6.3%
Slowing
πŸ“ŠGross Margin
73.0%
High
πŸ’΅FCF Margin
9.1%
Moderate
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
β€”
Insufficient data
No chart data available for CTEV.

Trading Snapshot

Day Range
β€”
52-Week Range
$11.50 – $73.68
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
16.9M
Next Earnings
2026-11-09

Fundamentals Snapshot

Annual Revenue
$965M
Last Q Revenue
$257M
P/E Ratio
β€”
P/S Ratio
0.4x
EPS (TTM)
$-17.01
Dividend Yield
β€”
Dilution (1yr)
+1.8%
CTEV logo

CLARITEV CORP

CTEV
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$965Mβ–² +3.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
27.6%β–Ό βˆ’62.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$45Mβ–Ό βˆ’103.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$12Mβ–² +16.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
16.4Mβ–² +1.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$4.6Bβ–Ό βˆ’$91M YoY
StockOtter Β· stockotter.space

About CLARITEV CORP

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologiesβ€”including descriptive, predictive, and prescriptive analyticsβ€”to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.